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INTRODUCTION
The primary objective of a rubella immunization program-
me is to prevent the congenital rubella syndrome (CRS) (1).
Vaccination programmes have eliminated or greatly decreased
the rubella incidence and CRS in some developed countries
(2-4). For example, since the licensure of the rubella vaccine
in 1969, the numbers of reported cases of rubella and CRS
have decreased by over 99% in the United States (2, 3).
However, by 1997, 78 countries (92% of industrialized
countries, 36% of countries in economic transition, and 28%
of developing countries) had included the rubella vaccine in
their national immunization programmes (5). In Korea, rubel-
la vaccine had not been incorporated into the national immu-
nization programmes until 2000. However, measles, mumps,
and rubella (MMR) vaccine has been distributed free of charge
in public health centers for over 10 yr and used at private
sectors with a charge. Since 1997, a two-dose MMR vaccina-
tion programme was recommended in Korea. The immuniza-
tion rate of MMR has been over 80% since 1990 in a popu-
lation under 2 yr, but the 2nd dose immunization rate was
not high (<30%) among elementary school students (6).
Because rubella had not been a notifiable disease in Korea
until 2000, there are insufficient data on the incidence of rubel-
la and CRS. Like measles and mumps, rubella has also showed
a periodic epidemic feature every 4-5 yr. During the outbreak
from March to April 1996, 4,581 cases of rubella were report-
ed to the national centers by temporary surveillance system
(7). This outbreak also occurred among the vaccinated stu-
dent population. To prevent CRS, knowledge on the rubella
immunity in childbearing age women is important. Howev-
er, it is not sufficient without information on the seropreva-
lence of children, because virus circulation usually begins am-
ong children to spread out to adults. Moreover, in spite of the
immunization program for women at childbearing age, when
virus circulation continues among children, a few susceptible
pregnant women can be infected (8). Therefore, it is necessary
to identify seroprevalence of children as a source of infection.
The aim of the present study was to determine the age-spe-
cific rubella seroprevalence and the related factors among ele-
mentary school students from 1993 to 1999 in Gyeonggi Pro-
vince, Korea.
MATERIALS AND METHODS
Study Subjects
The study area was Gyeonggi Province, which is 10 to 50
kilometers off Seoul, the capital city of Korea. We selected
8 elementary schools according to area, by recommendation
of the Department of Education of the provincial office, all
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The aim of this study was to determe the age-specific rubella seroprevalence and
the related factors in Korean children. Subjects of the study were 5,393 students
from 8 elementary schools in Gyeonggi Province, Korea. Questionnaire surveys
with blood sampling were conducted in 1993, 1996, and 1999. ELISA tests, used
to detect rubella specific IgG antibody, were Imx (Abbott, U.S.A.) in 1993 and 1999,
and Enzygnost (Behring, Germany) in 1996. The age-adjusted rubella suscep-
tibility rate was 22.9% (95% CI: 22.8-23.0%) and it increased with age from 14%
to 28%. The susceptibility rates of vaccinees, nonvaccinees, and the unknown
group were 21%, 35%, and 27%, respectively (p=0.000). The rates by parental
education levels for elementary and below, middle school, high school, and col-
lege and over were 37%, 26%, 24%, and 20%, respectively. The geometric mean
titers (GMTs) of nonvaccinees, the unknown group, and vaccinees were 47 IU/mL,
42 IU/mL, and 37 IU/mL, respectively (p=0.000). The susceptibility level was too
high to prevent the rubella epidemic in Korea, which necessitates a programme
that will enhance the coverage for 1st and 2nd MMR vaccination among school
children. In particular, more attention should be paid to the vaccination of the chil-
dren whose parental education level is relatively low.
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of which included six grades to ensure the representativeness
of Gyeonggi Province. Four of them are located in rural areas
and the others in urban, and each of them represents eastern,
western, southern, and northern areas of Seoul (Fig. 1).
We surveyed the students of these schools repeatedly in
1993, 1996, and 1999, incorporating questionnaires with
serology tests. After testing rubella specific IgG antibody, we
mailed the results to the nursing teachers of the schools and
the parents of all study subjects. For students whose IgG anti-
body titer was very low, or negative, we administered the ru-
bella vaccine free of charge with consent of their parents and
then confirmed the serology of rubella after 5 weeks to 3 mon-
ths. Thereafter we gave a second vaccination to the students
who still remained negative for IgG antibody. The response
rate for the questionnaire survey was 99.7% and that for the
serological survey was 99.3%.
Questionnaires
We surveyed the general characteristics and the vaccination
history, using questionnaires. Since the study subjects were
elementary school students, their parents completed the ques-
tionnaires. We also reviewed the school health records and the
personal vaccination records of the study subjects. However,
most of the school records did not include data on MMR, be-
cause the vaccine was administered before school entry. Am-
ong the study subjects, the rate of available personal vaccina-
tion records were 30% in 1996 and 42% in 1999, and no
information was available in 1993 when we did not review
the records.
Serologic tests
After obtaining informed consents, blood samples were
obtained through venipuncture. The sera were separated and
stored at -70 until tested. Rubella-specific IgG antibod-
ies were screened quantitatively with the use of commercial
immunoassay kits (Imx Abbott, U.S.A. in 1993 and 1999,
and Enzygnost Behring, Germany in 1996). Although they
were not based on Korean population, the sensitivity, speci-
ficity, and accuracy of Abbotts Imx were 99.9%, 98.9%, and
99.8%, respectively (9). For the Behrings Enzygnost , the
sensitivity and specificity were 100% and 98.5%, respective-
ly (10). Even though all titers were calculated as IU/mL, there
were possibilities of systematic error. Therefore, the compar-
ison of titers was made by the year of survey.
Rubella specific IgG positivity indicates immunity against
rubella. However, there are various opinions on the cut-off
level for a definite immune status. In this study, we determined
the positive level at 10 IU/mL and over, based on the Rubel-
la Subcommittee of the National Committee for Clinical Lab-
oratory Standards (NCCLS) (11).
Statistical Analysis
The data were analysed by using the Statistical Package
SPSS 10.0 for Windows. We used a 5% significance level. Sero-
negative samples were excluded in computing geometric mean
titers (GMTs). We used the analysis of variance (ANOVA)
model for the comparison of the GMTs. For comparison of
the seronegativity between survey years, we calculated age-
adjusted rates by direct method, using the Gyeonggi popu-
lation in 1999. We used the chi-square test for comparing
seroprevalence rates. We fit the logistic regression model for
estimating age-adjusted odds ratios (OR).
RESULTS
General Characteristics of Study Subjects
Questionnaires and serological surveys were carried out in
8 elementary schools in 1993 (2,072 students), 1996 (1,665),
Survey year (No., %)
Total
(n=5,393)
1999
(n=1,656)
1996
(n=1,665)
1993
(n=2,072)
Characteristics
Gender
Male 1,013 (49) 862 (52) 850 (51) 2,725 (51)
Female 1,059 (51) 803 (48) 806 (49) 2,668 (49)
Area
Urban 1,097 (53) 1,030 (62) 939 (57) 3,066 (57)
Rural 975 (47) 635 (38) 717 (43) 2,327 (43)
Parental Education
Primary school 131 (6) 26 (2) 19 (1) 176 (3)
Middle school 379 (18) 154 (9) 114 (7) 647 (12)
High school 997 (48) 818 (49) 928 (56) 2,743 (51)
College 333 (16) 382 (23) 430 (26) 1,145 (21)
Missing 232 (11) 285 (17) 165 (10) 682 (13)
Table 1. Characteristics of children by survey year
Fig. 1. Geographical distribution of schools involved in this study.
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and 1999 (1,656). The gender distributions by survey year
and age were not significantly different. The study subjects
were 3,066 students (57%) for urban areas and 2,327 students
(43%) for rural areas. Socioeconomic status was assessed by
the education level of either the father or the mother, whichev-
er was greater. Parental education levels had increased grad-
ually over the survey years; the percentage as of middle school
and below were 24% in 1993, 11% in 1996, and 8% in 1999
(Table 1). The range of age was 6 to 12 yr, and the distribution
of age was not uniform. MMR vaccination rates by question-
naire were 54% in 1993, 71% in 1996, and 78% in 1999
(Table 2).
Rubella seroprevalence
The crude IgG antibody seronegative rate was 24.5%
(1,297/5,393) and the 95% confidence interval (CI) by bino-
mial distribution was from 22.9% to 25.2%. The overall rate
standardized by direct method using the Gyeonggi Province
population in 1999 was 22.9% (95% CI: 22.8- 23.0%), and
age-adjusted rates by the consecutive survey years were 22.4%,
24.6%, and 21.5% respectively. The differences between the
survey years were not significant. However, seronegative rates
by age were significantly different in 1993, 1996, and 1999,
respectively, and the trends by age were significant in 1996
(p=0.002) and in 1999 (p=0.000); the older the subjects, the
higher the negative rates. The seronegative rate of the vacci-
nees was 21%, and that of the nonvaccinees was 35%, while
that of the unknown group ( do not know or non-respon-
dents group) was 27% (p=0.000) (Table 2).
The age-adjusted seronegative rates by vaccination status
were also significantly different. The unvaccinated group had
twice the risk of being seronegative and the unknown group
had 1.3 times the risk compared with the vaccinated group.
The crude and age-adjusted rubella seronegative rates over
survey years were not significantly different. However, the age-
adjusted seronegative rates among vaccinees in 1996 was 1.4
times higher than that of 1993.
Rubella-specific IgG negative rates by gender were 26%
for male and 22% for female. The difference was still signif-
icant after age adjustment. Among vaccinees, age-adjusted
1993 1996 1999 Total
No. 
(% total)
No. (%)
seronegative
No. 
(% total)
No. (%)
seronegative
No. 
(% total)
No. (%)
seronegative
No. 
(% total)
No. (%)
seronegative
Total 2,072 (100) 485 (22.4*) 1,070 (100) 423 (24.6*) 1,694 (100) 389 (21.5*) 5,393 (100) 1,297 (22.9*)
Age (yr)
6 137 (7) 19 (14) 64 (4) 11 (17) 27 (2) 2 (7) 228 (4) 32 (14)
7 339 (16) 89 (26) 313 (19) 67 (22) 348 (21) 41 (12) 985 (18) 197 (20)
8 352 (17) 96 (27) 345 (21) 80 (23) 296 (17) 54 (19) 986 (18) 230 (23)
9 314 (15) 71 (23) 288 (17) 74 (26) 333 (20) 87 (26) 931 (17) 232 (25)
10 374 (18) 98 (26) 229 (14) 66 (29) 250 (15) 66 (27) 844 (16) 230 (27)
11 313 (15) 58 (19) 238 (14) 66 (28) 227 (13) 69 (31) 774 (14) 193 (25)
12 243 (12) 54 (22) 193 (12) 59 (31) 213 (13) 70 (33) 645 (12) 183 (28)
p 0.013 0.012 0.000 0.000
MMR Vaccination status
Unvaccinated 395 (19) 134 (34) 98 (6) 42 (43) 93 (6) 32 (34) 586 (11) 208 (35)
Unknown 567 (27) 149 (26) 381 (23) 105 (28) 266 (16) 71 (27) 1,214 (23) 325 (27)
Vaccinated 1,110 (54) 202 (18) 1,186 (71) 276 (23) 1,297 (78) 286 (22) 3,593 (67) 764 (21)
p 0.000 0.000 0.000 0.000
*Age-adjusted rates by direct method using Gyeonggi Province population at 1999.  p-value for the chi-square test.
Table 2. Rubella immunity status by survey year, age, and MMR vaccination
No. (%)
Seronegative
Crude
OR
ORa* 95%CI ORa 95%CI
MMR Vaccination status
Unvaccinated 208 (35) 2.0 2.0 1.6-2.4 --
Unknown 325 (27) 1.3 1.3 1.1-1.6 --
Vaccinated 764 (21) 1.0 1.0
Survey year
1999 389 (24) 1.0 1.0 0.86-1.2 1.3 1.0-1.5
1996 423 (25) 1.1 1.1 0.97-1.3 1.4 1.1-1.7
1993 485 (23) 1.0 1.0 1.0
Gender
Male 701 (26) 1.2 1.2 1.1-1.4 1.3 1.1-1.5
Female 596 (22) 1.0 1.0 1.0
Area
Urban 751 (25) 1.1 1.0 0.90-1.2 1.1 0.92-1.3
Rural 546 (24) 1.0 1.0 1.0
Parental Education 
Primary School 65 (37) 2.3 2.2 1.5-3.0 2.3 1.4-3.7
Middle School 171 (26) 1.4 1.4 1.1-1.7 1.4 1.0-1.8
High School 646 (24) 1.2 1.2 1.0-1.4 1.1 0.90-1.3
Missing 185 (27) 1.5 1.4 1.2-1.8 1.3 0.90-2.0
College 230 (20) 1.0 1.0 1.0
Table 3. Crude and age-adjusted odds ratios (OR) for the asso-
ciation between related factors and the seronegativity for rubella
*Odds ratio adjusted only by age.  Odds ratio adjusted only by age am-
ong the vaccinees.334 M. Ki, B.Y. Choi, M.-H. Kim, et al.
odds ratio of males against females was 1.3. Urban schools had
more seronegative students than rural, but the difference was
not significant. Rubella seronegative rates by parental edu-
cation levels were 37% for elementary school and below, 26%
for middle school, 24% for high school, 20% for college and
over, and 26% for the missing group. The trend of high neg-
ative rates by parental education level, excluding the missing
group, was statistically significant in 1993, 1999, and total.
Age-adjusted odds ratio for parental education level of elemen-
tary school and below was 2.2 against the college and over
group. The middle school graduated group had 1.4 times
greater risk than the college and over group. The rate of the
high school graduated group was not significantly different
from that of the college and over group. Among vaccinees,
the age-adjusted odds ratio for elementary school and below
was 2.3, which was statistically significant (Table 3).
Rubella IgG antibody titer
The GMT in 1993 was 46 IU/mL, which was significant-
ly higher than 34 IU/mL in 1996 and 36 IU/mL in 1999 (p=
0.000). The GMTs by age were significantly different in all
three survey years;  J shaped distribution appeared in 1993
and 1996, and a significant linear association was shown in
1999. In 1999, the GMTs by birth year showed a decreasing
pattern with increasing age (Fig. 2).
The GMTs by gender were not different. The GMTs of non-
vaccinees were the highest followed by the unknown and vac-
cinees in 1993 (p=0.001) and 1996 (p=0.002). In 1999, the
GMT of nonvaccinees was the highest also, but unknown
group had the lowest titer (p=0.274). The GMTs of nonvac-
cinees, unknown group and vaccinees were 47 IU/mL, 42 IU/
mL, and 37 IU/mL, respectively (p=0.000) (Fig. 3).
DISCUSSION
The study area, Gyeonggi Province reaches up to 10,135
km2, which comprises 10% of the total area of Korea, and 9
million in population, which comprises 19% of Korean pop-
ulation in 1999. The gross product was 19.5% of the GNP
(Gross National Product). The socioeconomic status of this
area was estimated to be at the median of the whole Korea.
Since the age distribution from 6 to 12 yr was not uniform,
we compared the rubella immunity by the age-adjusted odds
ratio. About 57% of the subjects lived in urban areas, which
was significantly higher than 43% of those in rural areas. How-
ever, the vaccination coverage rate and rubella seroprevalence
were similar between the urban and the rural because most
cities of Gyeonggi Province are small and relatively new, so
that the socioeconomic status of the urban areas was not much
higher than that of the rural.
Seroprevalence rate was determined by the vaccination rate
and the natural infection rate. A previous study conducted
during 1986-88 for 5 to 14 yr old Korean adolescents report-
ed susceptibility rates of 21.2% (n=824, ELISA of Abbott )
(12). In Korea, the rubella vaccine had been used popularly
since 1985. Therefore, it is surprising that a similar high sus-
ceptibility rate was found; 22.9% in this study, compared to
21.2% in the previous report years prior to the popular use
of the vaccine. Furthermore, after the rubella epidemic in
1996, the susceptibility rate of 1999 was still high enough
for another epidemic occurrence. To prevent an epidemic of
rubella, the herd immunity needs to be 83-85% at minimum.
However, as the circulating virus decreased in highly vacci-
nated countries, the need for a much higher immunity level
surfaced (13). So this susceptibility level evinces a sufficient
condition for the rubella and congenital rubella syndrome
epidemics to occur. 
Many factors potentially influence the rubella susceptibility
in child population. In the present analysis, rubella vaccina-
tion history, age, gender, and parental education level appeared
to be significant factors in the acquisition of rubella antibody;
residential area (urban or rural) did not appear to be signifi-
cant. However, these findings need to be compared with those
in other studies.
As expected, students with a rubella vaccination history had
lower susceptibility rates than those with null or unknown
history. The 21% susceptibility rate of those with a vaccination
history is supposed to implicate a combination of an inaccu-
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Fig. 2. Rubella IgG geometric mean titers (GMTs) of the seroposi-
tive population by survey year and birth year.
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rate vaccination history and vaccine failure; it is impossible to
separate the two in this analysis. Previous rubella vaccine stud-
ies have shown primary and secondary vaccine failure rates
ranging from 0-11% and 1-22%, respectively (14-19). In
Korea, primary vaccine failure rates also ranged from 0-12%
(20-22). Among seropositive children, the GMT in the unvac-
cinated was the highest in all three survey years. The differ-
ences were statistically significant except in 1999. The GMT
of the unvaccinated was from natural infection, so the high-
est titer in this group seems proper. The unknown group had
a mixed effect of natural infection and vaccination, so the titer
was lower than that in the unvaccinated group but higher than
that in the vaccinated group. These results support the fact
that the reinfection rate of the vaccinated group was higher
than that of the naturally immune group (23). In 1996 and
1999, the susceptibility rate increased with age, which reflects
the influence of vaccine. The younger age group had higher
vaccination rates than the older age group. Among the vac-
cinees, the younger age group had the lower secondary vac-
cine failure. The GMTs could also be explained by vaccina-
tion effect. In 1999, since most of the seropositive students
had immunity from vaccination, GMTs decreased with increas-
ing age. In 1993, however, there was no linear association
between age and susceptibility rate. This can be explained by
the complex effect of vaccination and natural infection. The
lower susceptibility in the younger age group might reflect
the influence of vaccination, while the lower susceptibility of
the older age group might reflect exposure to natural disease.
The GMTs in 1996 and 1993 showed a  J shape, which may
be explained by the vaccination effect and the natural infection
exposure effect. Students who had participated in the surveys
(although they were not the same students), the GMTs of the
previous survey were higher than those of the latter survey;
which means that the titer decreased as time passed. This
could explain the phenomenon that susceptibility increases
with age in each survey as well as in the consecutive survey
among the birth cohort.
Susceptibility rates were different by gender, which can be
attributed to the immunologic effect. In our study, rubella
immune loss rate during 3 yr was observed more frequently
among boys (24). In the rubella epidemic of Korea in 1996,
among 5 to 14 yr old, the incidence rate of boys (55/100,000)
was higher than that of girls (19/100,000). In measles studies,
the severity of disease and titers after vaccination were high-
er in females (25, 26). However, there was no relevant refer-
ence on rubella, so the gender factor is worth considering.
In this study, the susceptibility rates decreased with the in-
creasing level of parental education. It can be explained by the
fact that the children with parents of higher education had a
higher vaccination rate. However, among the vaccinees, the
susceptibility rate of those whose parental education level was
elementary school and below was higher. This might be
explained by inaccurate vaccination histories of the elementary
school and below group. Another explanation is a higher vac-
cine failure in the lower socioeconomic group, the lower socioe-
conomic group might not have received timely vaccination,
and had less booster vaccinations (27). The group that had
been vaccinated too early or too late caused more primary vac-
cine failures, and the group that had less booster vaccination
had more secondary vaccine failures. A large Mexican seroepi-
demiological study showed a significant increase in suscep-
tibility as the educational level decreased (28). However, am-
ong the unvaccinated population of Turkey, urban residence
area and higher socioeconomic groups were reported to have
lower susceptibility, but the socioeconomic factor was not sta-
tistically significant (29). Therefore, the effect of socioeconom-
ic status is different by country. This can be explained by the
difference of living conditions and adequate vaccination rates
according to the  socioeconomic status.
In conclusion, we observed a high susceptibility for rubel-
la in all three surveys, as well as in the period prior to the vac-
cine programme. It was explained by the insufficient vacci-
nation coverage rate and vaccine failure. Especially, 21% sus-
ceptibility rate in the vaccinated group necessitates a booster
rubella vaccination. At the same time, the lower socioeconom-
ic group had a significantly higher susceptibility rate in spite
of vaccination. In the coming years, serosurveillance studies
should focus on high-risk population, such as the lower socioe-
conomic group. To reach an enough level of herd immunity,
more effort is needed to increase the vaccination coverage rate.
REFERENCES
1. Center for Disease Control and Prevention. Measles, mumps, and
rubella-vaccine use and strategies for elimination of measles, rubella,
and congenital rubella syndrome and control of mumps: Recommen-
dation of the Advisory Committee on Immunization Practices (ACIP).
MMWR 1998; 47: 1-57.
2. Center for Disease Control and Prevention. Rubella and congenital
ruella syndrome: United States, Jan 1,1991-May 7, 1994. MMWR
1994; 43: 397-401.
3. Center for Disease Control and Prevention. Rubella and congenital
rubella syndrome: United States, 1994-1997. MMWR 1997; 46: 350-4.
4. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V,
Cantell K. The elimination of indigenous measles, mumps, and rubel-
la from Finland by a 12-year, two-dose vaccination program. N Engl J
Med 1994; 331: 1397-402.
5. Robertson SE, Cutts FT, Samuel R, Dias-Ortega JL. Control of rubel-
la and congenital rubella syndrome (CRS) in developing countries.
Part 2: vaccination against rubella. B World Health Org 1997; 75:
69-80.
6. Ministry of Health and Welfare. Expanded Program on Immunization
(EPI). The annual report of health and welfare, 2000. Available from
URL: http://www.mohw.go.kr/hp/owa
7. National Institute of Health-Korea. Communicable Diseases Month-
ly Report. Seoul: National Institute of Health-Korea, 7, 1996.
8. Pecham C. Congenital rubella in the United Kingdom before 1970:336 M. Ki, B.Y. Choi, M.-H. Kim, et al.
the preventive era. Rev Infect Dis 1985; 7: S11-6.
9. Schaefer LE, Dyke JW, Meglio FD, Murray PR, Crafts W, Niles AC.
Evaluation of microparticle enzyme immunoassays for immunoglob-
ulins G and M to rubella virus and Toxoplasma gondii on the Abbott
Imx automated analyzer. J Clin Microbiol 1989; 27: 2410-3.
10. Behring. Enzygnost Anti-Rubella-Virus/IgG Package Insert, 1998.
11. Skendzel LP. Rubella Immunity. Defining the level of protective anti-
body. Am J Clin Pathol 1996; 106: 170-4.
12. Lee IS, Kim CH, Lee SJ, Cho TH. Measurement of serum rubella anti-
body titers in Korean children, female adolescents, and pregnant wo-
men. Asia Oceania J Obstet Gynaecol 1992; 18: 345-53.
13. Fine PEM. Herd Immunity: History, Theory, Practice. Epidemiol Rev
1993; 15: 265-302.
14. Balfour HH Jr, Groth KE, Edelman CK. RA27/3 Rubella vaccine, a
four year follow-up. Am J Dis Child 1980; 134: 350-3.
15. Asahi T, Ueda K, Hidaka Y, Miyazaki C, Tanaka Y, Nishima S. Twen-
ty-three year follow-up study of rubella antibodies after immunization
in a closed population, and serological response to revaccination.
Vaccine 1997; 15: 1791-5.
16. Chu SY, Bernier RH, Stewart JA, Herrmann KL, Greenspan JR, Hen-
derson AK, Liang AP. Rubella antibody persistence after immuniza-
tion: sixteen-year follow-up in the Hawaiian Islands. JAMA 1988; 259:
3133-6.
17. O Shea S, Best JM, Banatvala JE, Marshall WC, Dudgeon JA. Rubel-
la vaccination: persistence of antibody for up to 16 years. Br Med J
1982; 285: 253-5.
18. Christenson B, Bottiger M. Long-term follow-up study of rubella anti-
bodies in naturally immune and vaccinated young adults. Vaccine
1994; 12: 41-5.
19. Knox EG. Theoretical aspects of rubella vaccination strategies. Rev
Infect Dis 1985 (Suppl 1); 7: S194-7.
20. Choi B, Shin YJ, Park HB, Yoon BJ, Hahn JS. A study on the positive
rate of rubella antibody and the sero-conversion rate after rubella
vaccination: students of 9 girls high schools in Gyeonggi-do, Korea.
Korean J Epidemiol 1993; 14: 173-84.
21. Park KS, Kim HS. Seroprevalence of rubella antibodies and effects
of vaccination among healthy university women students in Korea.
Yonsei Med J 1996; 37: 420-6.
22. Min CH, Lee JH, Cho MK. A study of immunogenicity of measles,
mumps and rubella vaccine prepared from human diploid cell. J
Korean Soc Microbiol 1991; 26: 487-91.
23. Horstmann DM, Liebhaber H, Le Bouvier GL, Rosenberg DA, Hal-
stead SB. Rubella reinfection of vaccinated and naturally immune
persons exposed in an epidemic. N Engl J Med 1970; 283: 771-8.
24. Ki MR, Kim MH, Choi BY, Shin YJ, Park TS. Rubella antibody loss
rates in Korean children. Epidmiol Infection 2002; 129: 557-64.
25. Black FL. Measles. In: KR Evanse AS, ed. Viral infections of humans,
epidemiology and control. 4 ed. New York: Plenum publishing Co,
1997.
26. Brody JA, Sever JL, Edgar A, McNew J. Measles antibody titer in mul-
tiple sclerosis patient and their siblings. Neurology 1972; 22: 492-9.
27. Ki MR, Kim MH, Shin YJ, Choi BY. MMR immunization rate and
related factors. J Korean Pediatr Soc 2001; 44: 375-88.
28. Gutierrez Trujillo G, Munoz O, Tapia Conyer R, Bustamante Calvil-
lo ME, Alvarez y Munoz MT, Guiscafre Gallardo JP, Magos C, Sepul-
veda J. The seroepidemiology of rubella in Mexican women; a nation-
al probability survey. Salud Pubilica Mex 1990; 32: 623-31.
29. Aksit S, Egemen A, Ozacar T, Kurugol Z, Keskinoglu P, Tasbakan
M, Caglayan S. Rubella seroprevalence in an unvaccinated popula-
tion in Izmir: recommendations for rubella vaccination in Turkey.
Pediatr Infect Dis J 1999; 18: 577-80.